Biotech

All Articles

Ideaya bags option on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is actually betting $400 million in biobucks that a bispecific antibody-drug con...

Takeda takes $140M loss on stopped working epilepsy medicine, proclaims FDA manage

.We currently recognize that Takeda is planning to locate a path to the FDA for epilepsy medicine so...

VBI Vaccinations files for bankruptcy, looks for property sale

.Immunology biotech VBI Vaccinations is actually veering hazardously close to the climax, with plans...

Celldex anti-cKIT antitoxin decrease colonies in an additional phase 2 research study

.It is actually difficult to muscular tissue in on a space as competitive as immunology, yet Celldex...

Boehringer offers up to $1.3 B for gate inhibitor biotech

.Boehringer Ingelheim is offering up to $1.3 billion for Nerio Therapies as well as a preclinical im...

Ventyx's last resort for inflammatory med sides in Crohn's breakdown

.Ventyx Biosciences' Crohn's illness medicine did certainly not help clients accomplish remission in...

Cognition's period 2 sparkle records taint Alzheimer's possibility

.Knowledge Rehabs' period 2 luster test has actually taken a few of the radiance off the Alzheimer's...

BMS axes bispecific months after submitting to work period 3 trial

.Bristol Myers Squibb has actually possessed a whiplash change of heart on its own BCMA bispecific T...

Charles Baum takes over Terremoto as CEO

.Charles Baum, M.D., Ph.D., who looked after Mirati Therapies' $ 5.8 billion purchase to Bristol Mye...

Asarina to shut after initiatives to companion Tourette's medication fall short

.After connecting to much more than 200 companies to partner a Tourette disorder therapy that reveal...